Peninsula Wealth’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$3.86M Sell
41,786
-894
-2% -$80.5K 0.66% 23
2024
Q3
$3.7M Buy
42,680
+8,242
+24% +$629K 0.65% 23
2024
Q2
$2.41M Buy
34,438
+127
+0.4% +$8.47K 0.45% 29
2024
Q1
$2.51M Sell
34,311
-99
-0.3% -$7.61K 0.5% 24
2023
Q4
$2.79M Sell
34,410
-792
-2% -$61.6K 0.58% 21
2023
Q3
$2.73M Sell
35,202
-12
-0% -$923 0.64% 19
2023
Q2
$2.71M Buy
35,214
+188
+0.5% +$15K 0.71% 21
2023
Q1
$2.91M Buy
35,026
+44
+0.1% +$3.64K 0.84% 19
2022
Q4
$3M Sell
34,982
-162
-0.5% -$12.8K 0.95% 18
2022
Q3
$2.17M Buy
35,144
+359
+1% +$22.6K 0.77% 19
2022
Q2
$2.15M Sell
34,785
-61
-0.2% -$3.78K 0.73% 19
2022
Q1
$2.07M Sell
34,846
-1,158
-3% -$74K 0.59% 19
2021
Q4
$2.61M Sell
36,004
-91
-0.3% -$6.27K 0.7% 19
2021
Q3
$2.52M Sell
36,095
-35,368
-49% -$2.48M 0.8% 17
2021
Q2
$4.92M Sell
71,463
-2,336
-3% -$156K 1.61% 14
2021
Q1
$4.77M Buy
73,799
+27
+0% +$1.74K 1.71% 14
2020
Q4
$4.3M Buy
73,772
+6
+0% +$362 1.61% 14
2020
Q3
$4.66M Sell
73,766
-131
-0.2% -$9.08K 2% 12
2020
Q2
$5.69M Sell
73,897
-19
-0% -$1.46K 2.65% 9
2020
Q1
$5.53M Sell
73,916
-226
-0.3% -$15.6K 3.09% 8
2019
Q4
$4.82M Sell
74,142
-461
-0.6% -$30K 2.23% 7
2019
Q3
$4.73M Buy
74,603
+5
+0% +$327 2.36% 7
2019
Q2
$5.04M Buy
74,598
+27
+0% +$1.78K 2.59% 7
2019
Q1
$4.85M Buy
74,571
+5
+0% +$332 2.68% 7
2018
Q4
$4.66M Buy
74,566
+5
+0% +$349 2.91% 8
2018
Q3
$5.76M Buy
74,561
+3
+0% +$227 3.1% 7
2018
Q2
$5.28M Buy
74,558
+5
+0% +$353 3.1% 7
2018
Q1
$5.62M Buy
+74,553
New +$5.93M 3.35% 7

Other funds holding GILD

Peninsula Wealth's GILD Position: Q4 2024 in Review

Peninsula Wealth reduced its Gilead Sciences (GILD) stake by 2.1% in Q4 2024, selling an estimated $80.5K and leaving 41,786 shares worth $3.86M. The position accounts for 0.66% of the portfolio, ranked #23.

Peninsula Wealth first reported a position in GILD in Q1 2018 and has held it in 28 quarters since. The position peaked at $5.76M in Q3 2018. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • Peninsula Wealth held 41,786 shares of Gilead Sciences worth $3.86M as of Q4 2024.
  • Peninsula Wealth sold 894 Gilead Sciences shares in Q4 2024, an estimated $80.5K.
  • Gilead Sciences made up 0.66% of Peninsula Wealth's portfolio in Q4 2024, its #23 holding.
  • Peninsula Wealth first reported a position in Gilead Sciences in Q1 2018 and has held it in 28 quarters since.
  • Peninsula Wealth's Gilead Sciences position peaked at $5.76M in Q3 2018.
  • 1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Peninsula Wealth's 13F filing for Q4 2024, filed 13 Feb 2025.